Ustekinumab again linked to cardiovascular events

WAIKOLOA, HAWAII – The anti-interleukin-12/23 biologic agents ustekinumab and briakinumab were associated with a statistically significant 4.23-fold increased risk of major adverse cardiac events in...

Field of Interest: Dermatology
Type: News Item

Adding HbA1c doesn’t improve CVD risk assessment

Adding hemoglobin A1c level to traditional cardiovascular risk factors doesn’t improve the prediction of incident cardiovascular disease among middle-age and older adults who don’t have...

Field of Interest: Endocrinology
Type: News Item

Colchicine may provide potent cardiac protection

SNOWMASS, COLO. – Evidence from three observational studies suggests colchicine has a strong protective effect against cardiovascular events in gout patients. These data add to mounting evidence...

Field of Interest: Cardiology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness